SYK ubiquitination by CBL E3 ligases restrains cross-presentation of dead cell-associated antigens by type 1 dendritic cells

被引:3
|
作者
Henry, Conor M. [1 ,5 ]
Castellanos, Carlos A. [1 ]
Buck, Michael D. [1 ]
Giampazolias, Evangelos [1 ,6 ]
Frederico, Bruno [1 ]
Cardoso, Ana [1 ]
Rogers, Neil C. [1 ]
Schulz, Oliver [1 ]
Lee, Sonia [1 ]
Canton, Johnathan [1 ,7 ]
Faull, Peter [2 ,5 ]
Snijders, Ambrosius P. [2 ,8 ,9 ]
Mohapatra, Bhopal [3 ]
Band, Hamid [4 ]
Sousa, Caetano Reis e [1 ]
机构
[1] Francis Crick Inst, Immunobiol Lab, 1 Midland Rd, London NW1 1AT, England
[2] Francis Crick Inst, Prot Anal & Prote Platform, 1 Midland Rd, London NW1 1AT, England
[3] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA
[4] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA
[5] Roche Prod Ltd, Welwyn Garden City AL7 1TW, Herts, England
[6] Univ Manchester, Canc Res UK Manchester Inst, Canc Immunosurveillance Grp, Alderley Pk, Manchester M13 9PL, England
[7] Univ Calgary, Fac Vet Med, Comparat Biol & Expt Med, Calgary, AB, Canada
[8] Northwestern Univ, Northwestern Prote Core Facil, Chicago, IL 60611 USA
[9] Life Sci Mass Spectrometry, Bruker Dalton, Banner Lane, Coventry CV4 9GH, England
来源
CELL REPORTS | 2023年 / 42卷 / 12期
基金
英国惠康基金; 英国医学研究理事会; 欧盟地平线“2020”;
关键词
C-CBL; TYROSINE KINASE; F-ACTIN; DYING CELLS; T-CELLS; RECEPTOR; ACTIVATION; DNGR-1; CD8(+); INFECTION;
D O I
10.1016/j.celrep.2023.113506
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cross-presentation of dead cell-associated antigens by conventional dendritic cells type 1 (cDC1s) is critical for CD8+ T cells response against many tumors and viral infections. It is facilitated by DNGR-1 (CLEC9A), an SYK-coupled cDC1 receptor that detects dead cell debris. Here, we report that DNGR-1 engagement leads to rapid activation of CBL and CBL-B E3 ligases to cause K63-linked ubiquitination of SYK and terminate signaling. Genetic deletion of CBL E3 ligases or charge-conserved mutation of target lysines within SYK abol-ishes SYK ubiquitination and results in enhanced DNGR-1-dependent antigen cross-presentation. We also find that cDC1 deficient in CBL E3 ligases are more efficient at cross-priming CD8+ T cells to dead cell -asso-ciated antigens and promoting host resistance to tumors. Our findings reveal a role for CBL-dependent ubiq-uitination in limiting cross-presentation of dead cell-associated antigens and highlight an axis of negative regulation of cDC1 activity that could be exploited to increase anti-tumor immunity.
引用
收藏
页数:24
相关论文
共 31 条
  • [21] Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen
    Jurjen M. Ruben
    Hetty J. Bontkes
    Theresia M. Westers
    Erik Hooijberg
    Gert J. Ossenkoppele
    Tanja D. de Gruijl
    Arjan A. van de Loosdrecht
    Cancer Immunology, Immunotherapy, 2015, 64 : 1419 - 1427
  • [22] Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen
    Ruben, Jurjen M.
    Bontkes, Hetty J.
    Westers, Theresia M.
    Hooijberg, Erik
    Ossenkoppele, Gert J.
    de Gruijl, Tanja D.
    van de Loosdrecht, Arjan A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (11) : 1419 - 1427
  • [23] Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+XCR1+ dendritic cells
    K M Silk
    J D Silk
    N Ichiryu
    T J Davies
    K F Nolan
    A J Leishman
    L Carpenter
    S M Watt
    V Cerundolo
    P J Fairchild
    Gene Therapy, 2012, 19 : 1035 - 1040
  • [24] CD36 or αvβ3 and αvβ5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8α+ murine dendritic cells
    Schulz, O
    Pennington, DJ
    Hodivala-Dilke, K
    Febbraio, M
    Sousa, CRE
    JOURNAL OF IMMUNOLOGY, 2002, 168 (12): : 6057 - 6065
  • [25] Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+ XCR1+ dendritic cells
    Silk, K. M.
    Silk, J. D.
    Ichiryu, N.
    Davies, T. J.
    Nolan, K. F.
    Leishman, A. J.
    Carpenter, L.
    Watt, S. M.
    Cerundolo, V.
    Fairchild, P. J.
    GENE THERAPY, 2012, 19 (10) : 1035 - 1040
  • [26] The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens (vol 22, pg 140, 2021)
    Canton, Johnathan
    Blees, Hanna
    Henry, Conor M.
    Buck, Michael D.
    Schulz, Oliver
    Rogers, Neil C.
    Childs, Eleanor
    Zelenay, Santiago
    Rhys, Hefin
    Domart, Marie-Charlotte
    Collinson, Lucy
    Alloatti, Andres
    Ellison, Cara J.
    Amigorena, Sebastian
    Papayannopoulos, Venizelos
    Thomas, David C.
    Randow, Felix
    Sousa, Caetano
    NATURE IMMUNOLOGY, 2021, 22 (03) : 391 - 391
  • [27] Influenza Virus and Poly(I:C) Inhibit MHC Class I-Restricted Presentation of Cell-Associated Antigens Derived from Infected Dead Cells Captured by Human Dendritic Cells
    Frleta, Davor
    Yu, Chun I.
    Klechevsky, Eynav
    Flamar, Anne-Laure
    Zurawski, Gerard
    Banchereau, Jacques
    Palucka, A. Karolina
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 2766 - 2776
  • [28] Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8+ T Cell Activation via Cross-Presentation in Type 1 Diabetes
    Liu, Chao
    Whitener, Robert L.
    Lin, Andrea
    Xu, Yuan
    Chen, Jing
    Savinov, Alexei
    Leiding, Jennifer W.
    Wallet, Mark A.
    Mathews, Clayton E.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [29] E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer
    Wang, Shuo
    Xu, Ling
    Che, Xiaofang
    Li, Ce
    Xu, Lu
    Hou, Kezuo
    Fan, Yibo
    Wen, Ti
    Qu, Xiujuan
    Liu, Yunpeng
    FEBS LETTERS, 2018, 592 (04) : 621 - 630
  • [30] Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells
    Cioca, DP
    Deak, E
    Cioca, F
    Paunescu, V
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (01) : 41 - 52